ANI Pharmaceuticals, Inc.

NASDAQ:ANIP

58.51 (USD) • At close September 13, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998
Omzet 486.816316.385216.136208.475206.547201.576176.842128.62276.32255.9730.0822.3010.4352.4741.2583.7810.49314.4390.2580.0780.0652.8341.747000.123
Kosten van de omzet 241.304138.785100.6187.15763.15473.02479.03248.7812.69211.4739.9749.1670.050.269000000000-0.02400
Brutowinst 245.512177.6115.526121.318143.393128.55297.8179.84263.6344.49720.108-6.8660.3852.2051.2583.7810.49314.4390.2580.0780.0652.8341.7470.02400.123
Brutowinstmarge 0.5040.5610.5350.5820.6940.6380.5530.6210.8340.7950.668-2.9840.8850.89111111111112,14611
Onderzoek- en ontwikkelingskosten 34.28622.31811.36916.00119.80615.3889.072.9062.8742.6781.71216.88944.18239.70613.68115.794.7513.8566.4099.1623.6914.7872.1421.8880.6611.4
Algemene en administratieve kosten 0000044.06331.5827.82921.15617.93516.3888.236.9815.945.6745.9614.3317.0253.0513.082.3271.7662.2991.6790.8531.113
Verkoop- en marketingkosten 00000000000000000000000000
Verkoop-, algemene en administratieve kosten 161.697124.04484.29464.98655.84344.06331.5827.82921.15617.93516.3888.236.9815.945.6745.9614.3317.0253.0513.082.3271.7662.2991.6790.8531.113
Overige kosten -0.15956.97248.03255.90151.318-0.550.055-0.0740.0410.16-0.3050.3540.1480.16820.3290.0430.090.1180.1010.1020.0930.0920.0930.1230.0910.27
Bedrijfskosten 195.983203.334143.695136.888126.96793.19368.57853.07830.9324.49119.2125.47251.31245.81439.68421.7949.17210.9999.56112.3456.1116.6454.5333.6891.6052.782
Bedrijfsresultaat 49.529-25.064-32.512-16.06416.35135.35928.32920.07932.720.0060.898-23.172-50.927-43.608-38.426-18.014-8.6793.44-9.302-12.267-6.046-3.811-2.786-3.665-1.605-2.659
Bedrijfsresultaat ratio 0.102-0.079-0.15-0.0770.0790.1750.160.1560.4280.3570.03-10.071-117.03-17.625-30.544-4.764-17.6030.238-36.006-157.495-92.313-1.345-1.594-1,832,455.5-1,604,941-21.611
Totaal overige inkomsten en kosten netto -29.657-37.601-23.546-9.898-13.194-0.55-0.848-6.7590.0410.16-0.305-4.328-0.008-1.912-8.967-17,407.164-7,575.756-1.077-0.750.250.08700.174000
Inkomen voor belasting 19.872-62.665-56.058-25.9623.15720.05116.3498.67821.73319.3790.126-27.84-51,608.504-46,196.216-47,527.768-17,425.178-7,584.4352,791.273-9,651.036-12.016-5.959-3.811-2.611000
Inkomen voor belasting ratio 0.041-0.198-0.259-0.1250.0150.0990.0920.0670.2850.3460.004-12.1-118,596.617-18,670.894-37,778.798-4,608.825-15,382.565193.32-37,356.294-154.279-90.991-1.345-1.494000
Belastingkosten 1.093-14.769-13.455-3.414-2.9374.55717.4254.7446.358-9.3680.02-0.1220.6822.5889.102-17,407.753-7,576.8510.6480.3490000-0.228-0.1990
Nettowinst 18.779-47.896-42.603-22.5486.09415.494-1.0763.93415.37528.7470.301-27.718-51.609-46.196-47.528-17.425-7.5842.791-9.651-12.016-5.959-3.811-2.611-3.437-1.406-2.659
Nettowinstmarge 0.039-0.151-0.197-0.1080.030.077-0.0060.0310.2010.5140.01-12.047-118.597-18.671-37.779-4.609-15.3830.193-37.356-154.279-90.991-1.345-1.494-1,718,597.5-1,406,259-21.611
WPA (Winst Per Aandeel) 0.95-2.95-3.38-1.880.511.33-0.0930.341.342.61-0.92-7.64-18.88-25.23-50.39-22.97-10.714.68-17.92-25.23-19.44-18.28-14.5-21.51-10.24-27.47
Verwaterde WPA 0.94-2.95-3.38-1.880.51.32-0.0930.341.322.59-0.92-7.64-18.88-25.23-50.39-22.97-10.714.68-17.92-25.23-19.44-18.28-14.5-21.51-10.24-27.47
EBITDA 109.3231.90814.7428.57460.8168.55157.21549.03339.64124.0441.703-22.904-50.77-41.528-29.321-17.971-8.594.634-8.451-12.165-5.953-3.719-2.675-3.542-1.514-2.52
EBITDA ratio 0.2250.1010.0680.1370.2940.340.3240.3810.5190.430.057-9.955-116.67-16.784-23.307-4.753-17.4210.321-32.712-156.186-90.894-1.312-1.531-1,771,060.5-1,513,976-20.475